SEC Company Response from Anixa Biosciences Inc (ANIX) (CIK 0000715446) (ANIX) — Apr 6, 2017
Anixa Biosciences Inc (ANIX) (CIK 0000715446)
Date: April 6, 2017 · CIK: 0000715446 · Accession: 0001513162-17-000108
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-217060
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Re: ITUS Corporation Registration Statement on Form S-3 File No. 333-217060
Dear Ms. Woo:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, ITUS Corporation (the “Company”) hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. Eastern Standard Time on Monday, April 10, 2017, or as soon as practicable thereafter.
Very truly yours,
/s/ Robert A. Berman
Show Raw Text
CORRESP 1 filename1.htm S-3 Acceleration Request ITUS CORPORATION 12100 Wilshire Boulevard, Suite 1275 Los Angeles, CA 90025 April 6, 2017 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attn: Jan Woo Re: ITUS Corporation Registration Statement on Form S-3 File No. 333-217060 Dear Ms. Woo: Pursuant to Rule 461 under the Securities Act of 1933, as amended, ITUS Corporation (the “Company”) hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. Eastern Standard Time on Monday, April 10, 2017, or as soon as practicable thereafter. Very truly yours, /s/ Robert A. Berman Name: Robert A. Berman Title: President and Chief Executive Officer